Allianz Asset Management GmbH Purchases 637 Shares of Penumbra, Inc. (NYSE:PEN)

Allianz Asset Management GmbH raised its position in Penumbra, Inc. (NYSE:PENFree Report) by 9.7% during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 7,182 shares of the company’s stock after buying an additional 637 shares during the quarter. Allianz Asset Management GmbH’s holdings in Penumbra were worth $1,807,000 at the end of the most recent reporting period.

Several other hedge funds have also recently made changes to their positions in PEN. Swiss National Bank grew its position in Penumbra by 1.1% during the third quarter. Swiss National Bank now owns 79,900 shares of the company’s stock worth $19,329,000 after buying an additional 900 shares in the last quarter. Charles Schwab Investment Management Inc. grew its position in Penumbra by 2.8% during the third quarter. Charles Schwab Investment Management Inc. now owns 239,103 shares of the company’s stock worth $57,841,000 after buying an additional 6,436 shares in the last quarter. Vanguard Personalized Indexing Management LLC grew its position in Penumbra by 10.1% during the third quarter. Vanguard Personalized Indexing Management LLC now owns 5,251 shares of the company’s stock worth $1,270,000 after buying an additional 481 shares in the last quarter. Pathstone Family Office LLC lifted its stake in Penumbra by 135.2% during the third quarter. Pathstone Family Office LLC now owns 1,976 shares of the company’s stock worth $478,000 after purchasing an additional 1,136 shares during the last quarter. Finally, Canada Pension Plan Investment Board bought a new stake in Penumbra during the third quarter worth about $4,233,000. 88.88% of the stock is currently owned by institutional investors.

Analyst Ratings Changes

Several brokerages have issued reports on PEN. JPMorgan Chase & Co. lowered Penumbra from an “overweight” rating to a “neutral” rating and dropped their price target for the stock from $284.00 to $250.00 in a research note on Friday, February 23rd. Needham & Company LLC reaffirmed a “hold” rating on shares of Penumbra in a research note on Wednesday, May 8th. Piper Sandler lowered their target price on Penumbra from $290.00 to $260.00 and set an “overweight” rating for the company in a research note on Wednesday, May 8th. Truist Financial lowered their target price on Penumbra from $290.00 to $280.00 and set a “buy” rating for the company in a research note on Friday, March 22nd. Finally, Canaccord Genuity Group lowered their target price on Penumbra from $284.00 to $272.00 and set a “buy” rating for the company in a research note on Wednesday, May 8th. Four investment analysts have rated the stock with a hold rating and seven have issued a buy rating to the company. According to data from MarketBeat, the company has an average rating of “Moderate Buy” and a consensus price target of $300.64.

Get Our Latest Research Report on PEN

Insider Buying and Selling

In related news, EVP Johanna Roberts sold 600 shares of the company’s stock in a transaction that occurred on Monday, April 1st. The stock was sold at an average price of $217.07, for a total value of $130,242.00. Following the sale, the executive vice president now owns 64,281 shares in the company, valued at approximately $13,953,476.67. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. In related news, EVP Johanna Roberts sold 600 shares of the company’s stock in a transaction that occurred on Monday, April 1st. The stock was sold at an average price of $217.07, for a total value of $130,242.00. Following the transaction, the executive vice president now directly owns 64,281 shares of the company’s stock, valued at approximately $13,953,476.67. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, Director Don W. Kassing sold 170 shares of the company’s stock in a transaction that occurred on Monday, April 1st. The shares were sold at an average price of $223.18, for a total value of $37,940.60. Following the completion of the transaction, the director now directly owns 1,175 shares in the company, valued at $262,236.50. The disclosure for this sale can be found here. Insiders have sold 16,970 shares of company stock worth $3,420,669 in the last 90 days. Insiders own 5.00% of the company’s stock.

Penumbra Stock Down 3.8 %

PEN stock opened at $188.95 on Monday. Penumbra, Inc. has a fifty-two week low of $180.93 and a fifty-two week high of $348.67. The business’s 50 day moving average price is $204.63 and its two-hundred day moving average price is $230.79. The company has a debt-to-equity ratio of 0.02, a quick ratio of 3.51 and a current ratio of 6.12. The company has a market capitalization of $7.32 billion, a price-to-earnings ratio of 79.73, a price-to-earnings-growth ratio of 1.92 and a beta of 0.59.

Penumbra (NYSE:PENGet Free Report) last posted its quarterly earnings results on Tuesday, May 7th. The company reported $0.41 earnings per share for the quarter, missing the consensus estimate of $0.42 by ($0.01). The company had revenue of $278.70 million during the quarter, compared to analysts’ expectations of $274.94 million. Penumbra had a return on equity of 7.83% and a net margin of 8.52%. The business’s quarterly revenue was up 15.5% on a year-over-year basis. During the same quarter in the previous year, the company earned $0.23 EPS. As a group, analysts forecast that Penumbra, Inc. will post 2.87 earnings per share for the current fiscal year.

Penumbra Profile

(Free Report)

Penumbra, Inc, together with its subsidiaries, designs, develops, manufactures, and markets medical devices in the United States and internationally. The company offers peripheral products, including the Indigo System for power aspiration of thrombus in the body; Lightning Flash, a mechanical thrombectomy system; Lightning Bolt 7, an arterial thrombectomy system; and CAT RX.

Recommended Stories

Want to see what other hedge funds are holding PEN? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Penumbra, Inc. (NYSE:PENFree Report).

Institutional Ownership by Quarter for Penumbra (NYSE:PEN)

Receive News & Ratings for Penumbra Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Penumbra and related companies with MarketBeat.com's FREE daily email newsletter.